EODData

FRA, 3XV: XVIVO PERFUSION AB

03 Nov 2025
LAST:

17.09

CHANGE:
 0.01
OPEN:
17.09
HIGH:
17.09
ASK:
0.00
VOLUME:
25
CHG(%):
0.06
PREV:
17.08
LOW:
17.09
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Nov 2517.0917.0917.0917.0925
31 Oct 2517.0817.0817.0817.0825
30 Oct 2517.3317.3317.3317.3325
29 Oct 2517.0717.0717.0717.0725
28 Oct 2517.4817.4817.4817.4825
27 Oct 2518.1918.1918.1918.1925
24 Oct 2516.4418.7116.4418.7125
23 Oct 2516.2916.9016.2916.90100
22 Oct 2516.2216.2216.2216.2240
21 Oct 2515.8115.8115.8115.8140

COMPANY PROFILE

Name:XVIVO PERFUSION AB
About:Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment. In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation. It operates in Sweden; The Netherlands; The United States; Italy; North and South America; Asia/Pacific and Oceania; and internationally. The company was incorporated in 1998 and is headquartered in Mölndal, Sweden.
Sector:Healthcare
Address:Gemenskapens gata 9, Mölndal, Sweden, 431 53
Website:https://www.xvivogroup.com
ISIN:SE0004840718
LEI:549300G2464FYLS14B41

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:44.91 
Forward P/E:24.57 
Price to Sales:0.59 
Price to Book:2.65 
Revenue:822.93M 
EBITDA:95.2M 
Shares:31.5M 
Market Cap:538.33M 

TECHNICAL INDICATORS

MA5:17.210.7%
MA10:17.190.6%
MA20:16.126.0%
MA50:15.838.0%
MA100:18.317.1%
MA200:25.4749.1%
STO9:34.94
STO14:61.97
RSI14:66.91 
WPR14:-38.03
MTM14:2.45
ROC14:0.17 
ATR:0.52 
Week High:18.196.4%
Week Low:17.070.1%
Month High:18.719.5%
Month Low:14.4549.1%
Year High:44.68161.5%
Year Low:14.4518.3%